Modeling the impact of universal tuberculosis molecular testing and timing of tuberculosis preventive treatment during antiretroviral therapy initiation in South Africa

Simple item page
dc.article.end-page2379en
dc.article.start-page2371en
dc.citation.doi10.1097/QAD.0000000000003707en
dc.contributor.authorR Balasubramanianen
dc.contributor.authorK Sheareren
dc.contributor.authorD Mudzengien
dc.contributor.authorP Hippneren
dc.contributor.authorE et alen
dc.contributor.authorViolet Chihotaen
dc.date.accessioned2024-07-23T06:01:02Z
dc.date.available2024-07-23T06:01:02Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0269-9370en
dc.identifier.urihttps://hdl.handle.net/10539/39618
dc.journal.titleModeling the impact of universal tuberculosis molecular testing and timing of tuberculosis preventive treatment during antiretroviral therapy initiation in South Africaen
dc.journal.volume37en
dc.publisherLIPPINCOTT WILLIAMS & WILKINSen
dc.titleModeling the impact of universal tuberculosis molecular testing and timing of tuberculosis preventive treatment during antiretroviral therapy initiation in South Africaen
dc.typeJournal Articleen
Files
Collections
Academic Wits Research Outputs (All submissions)